Teva's Earnings and Outlook Miss Estimates. Currency Moves Are to Blame. | Barron's
Teva stock drops 10% as generics turnaround looks uncertain - MarketWatch
A New CEO Only Emboldens the Case for Teva Pharmaceutical Industries Ltd ( TEVA) Stock
Teva shares hit 19-year low after opioid settlement, analyst downgrades | Fierce Pharma
Teva's latest quarter was even worse than already-low expectations - MarketWatch
IBD Live at MarketWatch's Best New Ideas In Money Festival 2022 - Day 2 - YouTube
Drugmaker Teva Pharmaceuticals found guilty for contribution to opioid crisis - MarketWatch
Teva Pharmaceuticals - Wikiwand
Teva Pharmaceuticals - Wikiwand
Warren Buffett Stocks Fall: Teva Pharmaceutical Up 1.8%; StoneCo Off 3.7% - TheStreet
Teva CEO Sees a Final Opioid Settlement Coming This Year | Barron's
Teva: Avoid (NYSE:TEVA) | Seeking Alpha
What To Do After TEVA Stock Falls Below $10 Again (NYSE:TEVA) | Seeking Alpha
Teva to acquire Mexico's Rimsa for $2.3 billion - MarketWatch
How Warren Buffett Triggered Teva's Epic Short Squeeze - New York Shock Exchange
TEVA -- Is Its Stock Price A Worthy Investment? Learn More.
Teva backs full-year guidance despite Q3 sales miss
Is the new Teva x Ugg collection fashion-forward or just plain ugly? - MarketWatch
Teva Pharmaceutical Industries - Updates, News, Events, Signals & Triggers
Teva Tries to Put an End to the Opioid Wars - WSJ
European Commission suspects pharma group Teva broke antitrust rules
Drug maker Teva agrees to $4.3 billion national settlement over opioid lawsuits - MarketWatch
Teva Appoints New Chief Executive After Months of Speculation - WSJ
TEVA — TradingView
Teva beats first-quarter expectations but still has the same old problems - MarketWatch
Teva Pharmaceutical Names Richard Francis as CEO, President - WSJ
